Navigation Links
Life Spine(R) Announces 510(k) Approval of SENTINEL(TM) OCT System
Date:9/30/2009

HOFFMAN ESTATES, Ill., Sept. 30 /PRNewswire/ -- Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing approval to the SENTINEL Occipito-Cervico-Thoracic (OCT) System.

The SENTINEL OCT System provides rigid stabilization and promotes fusion from the occiput to thoracic spine, and features streamlined implants and instruments to address complicated procedures. Polyaxial screws are available in multiple diameters and lengths, and offer a generous cone angulation, which simplifies alignment with the rod and minimizes rod contouring.

The addition of the SENTINEL OCT System to the current broad product offering is a watershed event providing the ability to offer surgeons a full range of solutions to address spinal pathologies from the occiput to the sacrum. The SENTINEL OCT System makes its mark as the twentieth 510(k) approval to date for Life Spine.

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Hoffman Estates, Illinois. For more information, please visit http://www.lifespine.com.

SOURCE Life Spine


'/>"/>
SOURCE Life Spine
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
2. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
3. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
4. Mardil, Inc. Announces Positive Preliminary Results of Pilot Study With BACE(TM) Device at Annual TCT Conference
5. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
6. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
7. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
8. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
9. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
10. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
11. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
(Date:9/5/2017)... another milestone in their continued growth and success of the company.  Xyntek has ... engagements regionally.  ... at 318 West Adams Street, Suite 1528, Chicago, IL ... Xyntek's recently opened Midwest office will support the ... In addition to Xyntek,s headquarters ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... 20, 2017 , ... The Centers for Medicare and Medicaid Services (CMS) stated ... to using only Worksheet S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated Care Payments ... complimentary webinars on October 17, 2017 at 2 P.M. EST and uncover how ...
(Date:9/20/2017)... ... 20, 2017 , ... “RECYCLED Ezekiel's Plan for Freedom from ... from ADDICTION” is the creation of published author, Bill Miller. Bill Miller ... services, including more than a decade of addiction to prescription drugs. He ...
(Date:9/20/2017)... ... ... Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning to see the ... a busy mother of five who used her time waiting for children to finish their ... twenty years. It was a way to give some meaning to the hours I ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... has joined its executive team as the President of its HealthBI division. ... management systems and contact centers. , “Scott is a utility player who ...
Breaking Medicine News(10 mins):